TOPLINE: Treatment with cendakimab, an investigational anti–interleukin-13 monoclonal antibody administered subcutaneously, is well tolerated and reduces the severity of atopic dermatitis (AD) and pruritus in adults […]

TOPLINE: Only 16% of the TikTok videos related to sun protection are created by board-certified dermatologists (BCDs), with beauty bloggers and patients being the predominant content […]

TOPLINE: The transvaginal ultrasonography triage strategy is unreliable for diagnosing endometrial cancer in high-risk Black women, with a significant risk for false-negative results at different endometrial […]

TOPLINE: Long-term gender-affirming hormone treatment with testosterone increases the risk for metabolic syndromes in transmasculine individuals, whereas transfeminine individuals receiving estradiol have a lower risk. METHODOLOGY: […]

TOPLINE: More than a third of substance-use treatment facilities do not offer medications for opioid use disorder (MOUD), and less than half were offered evidence-based psychosocial […]

TOPLINE: For patients with head and neck squamous cell carcinoma, utilizing fluorodeoxyglucose-(FDG)-PET/CT imaging to assess their response to chemoradiation significantly increases the accuracy in identifying which […]

TOPLINE: A high-fiber diet affects small intestine metabolism, spurring release of the appetite-suppressing gut hormone peptide tyrosine tyrosine (PYY) more than a low-fiber diet, and it […]

TOPLINE: A perioperative enhanced recovery protocol significantly improved the postoperative outcomes in patients undergoing ileocecal resection for Crohn’s disease, speeding discharge readiness and reducing complications and […]

TOPLINE: The use of menopausal hormone therapy (MHT) increases breast cancer risk in women with a strong family history of breast cancer. These women have a […]